Challenges in Determining and Targeting Cancer Cells

The 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 took place in Madrid, Spain, and brought together leading clinicians and researchers who discussed several topics. In this podcast series, you will hear the latest updates in the treatment of multiple myeloma and gain an insight into the sessions that took place at this year’s meeting.

In this podcast, Leif Bergsagel, MD, Mayo Clinic, Phoenix, AZ, Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, Jill Corre, PharmD, PhD, The Cancer University Institute of Toulouse Oncopole (IUCT), Toulouse, France, and Niels Weinhold, PhD, University Hospital Heidelberg, Heidelberg, Germany, discuss the genomics of high-risk multiple myeloma and smoldering myeloma. Topics covered include the importance of next-generation sequencing (NGS), the role of del(17p) and TP53 mutations, and more.

The post iwMyeloma Session I: genomics of high-risk and smoldering multiple myeloma appeared first on VJHemOnc.